Here are four things to know.
1. The FDA launched an investigation of Hyland’s Homeopathic’s teething products after it received reports of 400 adverse events and 10 child deaths relating to the products.
2. After finding inconsistent amounts of belladona in the products, the FDA reached out to Standard Homeopathic Company — which manufactures Hyland’s teething products — in late January asking them to recall the homeopathic teething tablet products.
3. While Hyland’s asserts its products are safe, the company responded to the FDA’s request and has now recalled all lots of Hyland’s teething products. The company stopped manufacturing and selling the products in October.
4. Standard Homeopathic notified its distributors and retailers about the recall and is working with them to return the products. Any customers who own the product should discard it immediately, according to the company.
More articles on supply chain:
Global pharmerging market to reach $1.4B by 2025
FDA OKs Tecentriq for advanced bladder cancer
PBM lobby group: No correlation between drug prices and rebates
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.